Shahab Uddin Selected Research

sanguinarine

12/2021	Sanguinarine mediated apoptosis in Non-Small Cell Lung Cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway.
11/2021	Reactive oxygen species (ROS) in cancer pathogenesis and therapy: An update on the role of ROS in anticancer action of benzophenanthridine alkaloids.
3/2020	Sanguinarine Induces Apoptosis in Papillary Thyroid Cancer Cells via Generation of Reactive Oxygen Species.
1/2019	Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling.
1/2019	Sanguinarine suppresses growth and induces apoptosis in childhood acute lymphoblastic leukemia.
1/2017	Anticancer potential of sanguinarine for various human malignancies.
4/2007	Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shahab Uddin Research Topics

Disease

88	Neoplasms (Cancer) 11/2022 - 10/2005
19	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 03/2006
12	Neoplasm Metastasis (Metastasis) 10/2022 - 01/2017
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2014 - 12/2006
9	Carcinogenesis 01/2022 - 12/2007
8	Leukemia 12/2020 - 08/2003
7	Inflammation (Inflammations) 10/2022 - 01/2004
7	Papillary Thyroid Cancer 03/2020 - 07/2008
7	Lymphoma (Lymphomas) 02/2014 - 12/2007
6	Primary Effusion Lymphoma 01/2012 - 04/2005
5	Breast Neoplasms (Breast Cancer) 01/2022 - 08/2003
5	Ovarian Epithelial Carcinoma 05/2015 - 09/2009
4	Disease Progression 11/2022 - 01/2018
4	Ovarian Neoplasms (Ovarian Cancer) 06/2022 - 09/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2021 - 01/2019
4	Hematologic Neoplasms (Hematological Malignancy) 02/2021 - 01/2016
4	Multiple Myeloma 07/2020 - 10/2008
4	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 07/2008
4	Obesity 10/2019 - 09/2009
3	Infections 12/2022 - 11/2018
3	B-Cell Lymphoma (Lymphoma, B Cell) 05/2020 - 01/2012
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 07/2007
3	Testicular Neoplasms (Testicular Cancer) 01/2020 - 01/2018
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2016 - 05/2005
3	Acute Promyelocytic Leukemia 03/2009 - 08/2003
2	COVID-19 12/2022 - 01/2021
2	Adenocarcinoma of Lung 01/2021 - 11/2020
2	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2019
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 01/2018
2	Necrosis 01/2017 - 07/2010
2	Carcinoma (Carcinomatosis) 11/2009 - 11/2009

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2003
14	Phosphotransferases (Kinase)IBA 01/2022 - 06/2002
11	CytokinesIBA 11/2022 - 06/2002
10	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2010
8	Biological ProductsIBA 12/2021 - 02/2005
7	sanguinarineIBA 12/2021 - 04/2007
7	Cisplatin (Platino)FDA LinkGeneric 11/2020 - 01/2011
7	Pharmaceutical PreparationsIBA 01/2020 - 01/2008
7	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019 - 07/2004
6	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022 - 04/2011
6	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2021 - 04/2005
6	CurcuminIBA 01/2020 - 10/2005
6	Bortezomib (Velcade)FDA Link 03/2016 - 05/2008
6	Leptin ReceptorsIBA 01/2016 - 09/2009
6	LeptinIBA 01/2016 - 09/2009
6	EnzymesIBA 01/2011 - 12/2007
5	LigandsIBA 11/2022 - 07/2010
5	ChemokinesIBA 11/2022 - 01/2018
5	Protein Kinases (Protein Kinase)IBA 01/2022 - 05/2008
5	NF-kappa B (NF-kB)IBA 01/2022 - 10/2008
4	AntigensIBA 12/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 06/2002
4	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2011 - 10/2008
3	Transcription Factors (Transcription Factor)IBA 10/2022 - 01/2012
3	CateninsIBA 06/2022 - 01/2019
3	XenobioticsIBA 06/2022 - 01/2008
3	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2019
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2019
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 05/2010
3	Thiostrepton (Gargon)IBA 12/2021 - 01/2012
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 09/2021 - 01/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2021 - 01/2004
3	Untranslated RNA (Noncoding RNA)IBA 12/2020 - 02/2020
3	LipidsIBA 05/2019 - 07/2011
3	DNA (Deoxyribonucleic Acid)IBA 05/2019 - 12/2007
3	embelinIBA 01/2018 - 07/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 05/2008
3	UbiquitinIBA 01/2018 - 05/2008
3	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 03/2012 - 01/2011
3	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 12/2011 - 07/2010
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2011 - 09/2010
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2009 - 08/2003
3	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2006 - 07/2004
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 06/2022 - 01/2022
2	Circular RNAIBA 03/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 02/2022 - 02/2021
2	F-Box ProteinsIBA 12/2021 - 02/2016
2	AntioxidantsIBA 11/2021 - 01/2017
2	AlkaloidsIBA 11/2021 - 01/2017
2	CarcinogensIBA 01/2020 - 01/2008
2	Janus KinasesIBA 01/2020 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 05/2011
2	pregna-4,17-diene-3,16-dione (guggulsterone)IBA 10/2019 - 01/2017
2	PhytochemicalsIBA 01/2019 - 01/2018
2	Protein Kinase CIBA 01/2019 - 08/2003
2	Proteasome InhibitorsIBA 03/2016 - 07/2009
2	ResveratrolIBA 01/2016 - 01/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 07/2015 - 01/2010
2	Calcibiotic Root Canal SealerIBA 02/2014 - 11/2009
2	thymoquinoneIBA 01/2013 - 04/2011
2	Proto-Oncogene Proteins c-metIBA 03/2012 - 01/2011
2	X-Linked Inhibitor of Apoptosis ProteinIBA 01/2012 - 10/2010
2	Protein Isoforms (Isoforms)IBA 12/2009 - 01/2004
2	Folic Acid (Vitamin M)FDA LinkGeneric 07/2008 - 12/2007

Therapy/Procedure

27	Therapeutics 12/2022 - 07/2007
6	Drug Therapy (Chemotherapy) 01/2021 - 04/2007
5	Immunotherapy 02/2022 - 01/2020
2	Radiotherapy 01/2020 - 11/2009